Pascoal Lab https://validator.w3.org/feed/docs/rss2.html VJ Dementia with Marina S. Medeiros Altered triple network model connectivity is associated with cognitive function and depressive symptoms in older adults Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohort Increased cerebrospinal fluid and plasma apoE glycosylation is associated with reduced levels of Alzheimer’s disease biomarkers Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer’s disease spectrum Pittsburgh plasma p-tau217: Classification accuracies for autosomal dominant and sporadic Alzheimer’s disease in the community Impact of racialization on neuroimaging and plasma biomarkers of Alzheimer’s disease Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease Pittsburgh plasma p-tau217: classification accuracies for autosomal dominant and sporadic Alzheimer’s disease in the community Plasma GFAP for populational enrichment of clinical trials in preclinical Alzheimer’s disease Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohort Tau profiling across Alzheimer’s disease staging reveals vulnerability to disease pathophysiology Exploring inflammation-related protein expression and its relationship with TSPO PET in Alzheimer’s disease Autoradiographic comparison between [11C]PiB and [18F]AZD4694 in human brain tissue In vivo-measured Lewy body pathology is associated with neuropsychiatric symptoms across the Alzheimer’s disease continuum Biofluid-based staging of Alzheimer’s disease Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer’s disease Brain age mediates gut microbiome dysbiosis-related cognition in older adults Pittsburgh is at the forefront of research for warning signs of Alzheimer’s disease Impact of the polygenic risk scores for attention-deficit/hyperactivity disorder in Alzheimer’s disease Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer’s disease Diagnostic performance of Alzheimer’s disease blood and CSF biomarkers in a Brazilian cohort with low educational attainment Comparison Between Brain and Cerebellar Autoradiography Using [18F]Flortaucipir, [18F]MK6240, and [18F]PI2620 in Postmortem Human Brain Tissue Three Psychiatry Postdoctoral Research Trainees Receive University of Pittsburgh Postdoctoral Association Awards 19 people were honored at Pitt’s Postdoctoral Research Symposium Investing in Hope Studies Gallery Comparison of Plasma p-tau217 and [18F]FDG-PET for Identifying Alzheimer Disease in People With Early-Onset or Atypical Dementia Social and health disparities associated with healthy brain ageing in Brazil and in other Latin American countries Team Identify biological Alzheimer’s disease using a novel nucleic acid-linked protein immunoassay Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability Identification of late-stage tau accumulation using plasma phospho-tau217 Plasma phosphorylated tau181 outperforms [18F] fluorodeoxyglucose positron emission tomography in the identification of early Alzheimer disease Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer’s disease Pitt Psychiatry Research Published in Alzheimer’s & Dementia Insights into the use of biomarkers in clinical trials in Alzheimer’s disease Blood testing for Alzheimer’s could be game changer in early diagnosis Pitt study could open opportunity for earlier Alzheimer’s detection UPMC recruiting participants for research study involving blood tests, early Alzheimer’s detection Omics-derived biological modules reflect metabolic brain changes in Alzheimer’s disease New Blood Biomarker Can Predict if Cognitively Healthy Elderly Will Develop Alzheimer’s Disease Association of plasma biomarkers of Alzheimer’s disease and related disorders with cognition and cognitive decline: The MYHAT population-based study Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease The HEAD Study – Pascoal Laboratory, University of Pittsburgh New research could be game-changer for early detection of Alzheimer’s Disease Cross-species comparative hippocampal transcriptomics in Alzheimer’s disease The relation of synapticbiomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer’s disease Home